Literature DB >> 3045326

Interactions between Escherichia coli RNA polymerase and lambda repressor. Mutations in PRM affect repression of PR.

J J Hwang1, G N Gussin.   

Abstract

The rightward operator, OR, of bacteriophage lambda is part of a complex regulatory region that includes PRM, the promoter for repressor synthesis by a prophage, the rightward early promoter PR, and three repressor-binding sites, OR1, OR2 and OR3. By binding to OR2, repressor blocks transcription from PR and simultaneously stimulates the formation of open complexes between RNA polymerase and PRM. In this letter, we describe a test of the hypothesis that the interaction between RNA polymerase bound at PRM and repressor bound at OR2 increases the apparent affinity of repressor for OR. One implication of this hypothesis is that the amount of repressor required for repression of PR should be inversely correlated with PRM promoter strength. This is indeed the case. The amount of repressor required for 50% repression of PR is decreased by prmup-1, an "up" mutation of PRM, and is increased by prm- mutations. An unexpected finding is that in addition to their effect on the apparent affinity of repressor for OR, mutations in the -35 region of PRM alter the shape of repressor-titration curves. We propose that these mutations alter the interaction between RNA polymerase bound at PRM and repressor bound at OR2 in such a way that cooperativity in the binding of repressor to OR1 and OR2 is also disrupted.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3045326     DOI: 10.1016/0022-2836(88)90484-6

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  10 in total

1.  Sequence tolerance of the phage lambda PRM promoter: implications for evolution of gene regulatory circuitry.

Authors:  Christine B Michalowski; Megan D Short; John W Little
Journal:  J Bacteriol       Date:  2004-12       Impact factor: 3.490

2.  Activation defects caused by mutations in Escherichia coli rpoA are promoter specific.

Authors:  G N Gussin; C Olson; K Igarashi; A Ishihama
Journal:  J Bacteriol       Date:  1992-08       Impact factor: 3.490

3.  Suppressor mutations in rpoA suggest that OmpR controls transcription by direct interaction with the alpha subunit of RNA polymerase.

Authors:  J M Slauch; F D Russo; T J Silhavy
Journal:  J Bacteriol       Date:  1991-12       Impact factor: 3.490

4.  Role of cis-acting sites in stimulation of the phage λ P(RM) promoter by CI-mediated looping.

Authors:  Christine B Michalowski; John W Little
Journal:  J Bacteriol       Date:  2013-05-24       Impact factor: 3.490

5.  Synergistic binding of the Vibrio fischeri LuxR transcriptional activator domain and RNA polymerase to the lux promoter region.

Authors:  A M Stevens; K M Dolan; E P Greenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-20       Impact factor: 11.205

6.  Identification of promoter mutants defective in growth-rate-dependent regulation of rRNA transcription in Escherichia coli.

Authors:  R R Dickson; T Gaal; H A deBoer; P L deHaseth; R L Gourse
Journal:  J Bacteriol       Date:  1989-09       Impact factor: 3.490

7.  Activation of the trpBA promoter of Pseudomonas aeruginosa by TrpI protein in vitro.

Authors:  J G Gao; G N Gussin
Journal:  J Bacteriol       Date:  1991-06       Impact factor: 3.490

8.  New Insights into the Phage Genetic Switch: Effects of Bacteriophage Lambda Operator Mutations on DNA Looping and Regulation of PR, PL, and PRM.

Authors:  Dale E A Lewis; Gary N Gussin; Sankar Adhya
Journal:  J Mol Biol       Date:  2016-09-24       Impact factor: 5.469

9.  RNA polymerases from Pseudomonas aeruginosa and Pseudomonas syringae respond to Escherichia coli activator proteins.

Authors:  J G Gao; G N Gussin
Journal:  J Bacteriol       Date:  1991-01       Impact factor: 3.490

10.  Mutations in TrpI binding site II that differentially affect activation of the trpBA promoter of Pseudomonas aeruginosa.

Authors:  J Gao; G N Gussin
Journal:  EMBO J       Date:  1991-12       Impact factor: 11.598

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.